The current institutional shareholding score of TG Therapeutics Inc is 7.00, ranking 50 out of 155 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 80.02%, representing a quarter-over-quarter increase of 23.29%. The largest institutional shareholder is ETHSX, holding a total of 345.15K shares, representing 0.29% of shares outstanding, with 11.54% increase in holdings.